FI Fast Break audio news: June 11, 2025
The latest FI Fast Break news podcast touches on a recent study that suggests GLP-1 weight-loss drugs alter the “taste perception” of users.
Tag: Ozempic
Steaks Are High: GLP-1 Drugs Reshape Beef Demand
GLP-1 drugs like Ozempic are reshaping consumer appetites, with nearly half of users eating less beef. As this trend accelerates, meat producers face a challenge, while plant-based brands are presented with an opportunity.
FI Fast Break audio news: May 28, 2025
The latest FI Fast Break news podcast touches on a new study suggesting that many GLP-1 drug users have reduced their beef intake.
The New Rules of Food Innovation in the Age of GLP-1
The popularity of GLP-1 medications is compelling brands to innovate with smarter portion sizes and functional ingredients. This shift represents a revolutionary convergence of biotech, nutrition science, and consumer demand, reshaping how food supports appetite management and metabolic health.
3 Key Takeaways From Natural Products Expo West
This week, Natural Products Expo West 2025 showcased trends in the natural and organic sectors from nearly 3,200 exhibitors. The show especially highlighted the impact of GLP-1 drugs on snacking habits.
GLP-1 Weight-Loss Craze Brightens Outlook for Yogurt
The growing popularity of GLP-1 weight-loss drugs is reshaping the yogurt market, as consumers increasingly seek protein-packed snacks. Multiple brands are innovating with high-protein, low-sugar options.
GLP-1 Drugs’ Ripple Effects, Circana’s Tips for Adapting to Them
The rapid adoption of weight-loss drugs is reshaping purchasing habits. Circana experts highlight opportunities for brands to align with GLP-1 users’ goals by offering tailored, portion-controlled products and leveraging personalized marketing strategies to capture this evolving market.
Alcohol Threats Abound: From Surgeon General to Dry Jan
Alcohol manufacturers, retailers, and foodservice segments have a lot to worry about heading into the new year, with Dry January and Surgeon General advisories advocating for sober-curious lifestyles. Time will tell if these movements make an impact.
Nestlé Protein Shots Touted as an Economical Ozempic Rival
Nestlé is tapping into the booming weight-loss market with Boost Pre-Meal Hunger Support, a 45-calorie whey-protein solution designed to reduce appetite. Experts caution consumers about the shots’ limited effectiveness.
GLP-1 Drugs: Food Industry Threat or Dieting Fad?
GLP-1 weight-loss drugs are transforming dieting culture, offering a relatively easy solution to weight loss. While these drugs may disrupt food consumption patterns, their long-term impact hinges on overcoming high dropout rates and premium pricing, one industry insider says.
Hacking Humans 2.0: Redefining Health with Gut Bacteria
With dreams of CPG integration, FitBiomics is producing probiotics designed by data mining the gut microbiomes of professional athletes. Is this the next big wellness trend?
3 Expert Predictions Regarding GLP-1 Drugs
GLP-1 weight-loss drugs are increasing consumers’ preference toward healthier, nutrient-dense food. Some trends experts feel reduced demand for high-calorie foods could hurt QSRs, at least in the near-term.
Protein and Smaller Portions: Weight-loss Drugs Redefining Consumer Food Demands
New research, conducted by food innovation firm Mattson, revealed that GLP-1 users have reported specific food preferences, including more protein and smaller portions.
The Supplement Market is Booming
From GLP-1 injectables to mushroom-based coffee alternatives, the booming supplement market is making nutrition easier to manipulate.
Appetite for Reduction: GLP-1 Drugs Fuel Grocery Decrease
The market for GLP-1 drugs is expected to reach $100 billion by 2030. Manufacturers and brands who want a piece of the low-sugar pie, so to speak, will have to offer the same.
FI News Review (February 23, 2024) – How Weight-Loss Drugs Impact Food and Beverage
FI Fast Break audio news: Feb. 21, 2024
The latest Food Institute Fast Break news podcast touches on the trend of “AI washing” by some major businesses.
Consumer Buzz: Top 3 Wellness Trends
Across the U.S, social chatter is shaping wellness conversations and boosting demand for related ingredients. Here are three wellness trends to watch, according to a new report from Brightfield Group. Immunity Now Within Brightfield’s Wellness …
FI News Review (February 9, 2024) – Wellness Versus Indulgence
Seven Health and Wellness Trends for Foodservice in the New Year
With the New Year underway, which health and wellness trends are food consumers gravitating towards? Which should the food industry focus on?
Analysis: Ozempic Likely to Impact Snack Manufacturers’ Bottom Line
The recent rise of Ozempic and other weight-loss drugs started with blowout results that drove shares of their manufacturers higher, then wound up cascading across seemingly disparate sectors. In 2023, Novo Nordisk, the manufacturer of …
Zepbound: Latest Weapon in Weight-Loss Drug Arsenal
Eli Lilly’s Zepbound, recently approved by the FDA, is the most potent weight-loss drug yet. Could it impact the food industry? At least one expert says ‘yes.’
FI Fast Break audio news: Nov. 1, 2023
The latest Fast Break Food Institute news podcast touches on “The Ozempic Effect” on the food and beverage industry.
A Weighty Issue: Ozempic, Wegovy Versions Considered for Kids
With 17% of children ages 10 to 17 considered obese, consideration is being given to whether diabetes drugs like Ozempic should be made available to kids. Health experts have concerns.
Advertisement
FI-Home-NEW-2020Gaps
Advertisement
Ozempic’s Business Impact: Weight Loss Drug Could Make Snack-Makers Tighten Belts
Blockbuster diabetes drugs like Ozempic and Wegovy, which have become the darlings of the weight-loss industry, could have an unintended side-effect: shrinking the bottom lines of major snack-making companies. Junk food has been widely blamed …
FI Fast Break audio news: Oct. 4, 2023
This week’s Food Institute news podcast touches on the latest innovations featured at fast-food drive-thrus.
Ozempic & Other Drugs: Explaining the Weight-Loss Medication Craze
Several medications approved to treat diabetes are being used as “miracle” weight-loss drugs, and the category continues to grow.